CVRx (CVRX) Capital Expenditures Growth (3y) (2023 - 2026)
CVRx (CVRX) Capital Expenditures Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.69 Bn | 175.40 Bn | 6.27 Bn | 1.64% |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn | 8.49% |
| 3 | Medtronic | 108.07 Bn | 98.85 Bn | 6.41 Bn | 8.89% |
| 4 | Boston Scientific | 67.93 Bn | 66.47 Bn | 3.61 Bn | 16.83% |
| 5 | Edwards Lifesciences | 48.11 Bn | 44.44 Bn | 1.29 Bn | 1.81% |
| 6 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn | 0.84% |
| 7 | GE HealthCare Technologies | 27.89 Bn | 25.60 Bn | 1.98 Bn | 7.57% |
| 8 | Smith & Nephew | 26.99 Bn | 26.42 Bn | - | - |
| 9 | Koninklijke Philips | 24.05 Bn | 20.92 Bn | 2.07 Bn | 2.15% |
| 10 | CVRx | 125.19 Mn | 52.89 Mn | 12.88 Mn | -20.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.19% |
| Dec 31, 2025 | -4.88% |
| Sep 30, 2025 | 3.77% |
| Jun 30, 2025 | 28.10% |
| Mar 31, 2025 | -27.00% |
| Dec 31, 2024 | -54.11% |
| Sep 30, 2024 | -39.25% |
| Jun 30, 2024 | -2.16% |
| Mar 31, 2024 | 108.62% |
| Dec 31, 2023 | 18.72% |
| Sep 30, 2023 | -30.86% |